elemene has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Duan, T; Hou, S; Li, Z; Scampavia, L; Spicer, TP; Wang, W; Xie, T; Yuan, Y | 1 |
| Hui, L; Liu, Z; Long, J | 1 |
2 other study(ies) available for elemene and Pancreatic Neoplasms
| Article | Year |
|---|---|
Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism.
Topics: Bortezomib; Humans; Pancreas; Pancreatic Neoplasms; Proteasome Endopeptidase Complex | 2023 |
Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Sesquiterpenes; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Zingiberaceae | 2019 |